1. D'Souza, M.P. & Harden, V.A. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nature Med. 2, 1293–1300 (1996).
2. Zhu, T. et al. Genotypic and phenotypic characterization of HIV-1 in patients with Primary infection. Science 261, 1179–1181 (1993).
3. Moore, J.P. & Ho, D.D. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9 Suppl. A., S117–S136 (1995).
4. Zolla-Pazner, S. Neutralization of several HIV01 primary isolates by sera from HlV-negative recipients of candidate HIV vaccines. In Onziòeme Colloque Des Cent Gardes: Retroviruses of Human AIDS and Related Animal Diseases, 27–29 October 1997, Marnes-la-Coquette, Paris, France (eds. Girard, M. & Dodet, B.).
5. Burton, D.R. A vaccine for HIV type 1: The antibody perspective. Proc. Natl. Acad. Sci. 94, 10018–10023 (1997).